The global fosfomycin market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of antibiotic-resistant bacteria and rising demand for fosfomycin in emerging economies such as China and India. Fosfomycin is an antibiotic that has been used for decades in the treatment of urinary tract infections (UTIs). It is also used as a prophylactic agent against UTIs in patients with spinal cord injuries or those who have undergone prostate surgery. Fosfomycin has been found to be effective against Gram-negative bacteria, including E. coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis and Pseudomonas aeruginosa.
The global fosfomycin market by type includes fosfomycin calcium (CAS: 61491-07-2), fosfomycin sodium (CAS: 61491-08-3) and fosfomycin trometamol (CAS: 61491-09-4). The application segment includes injection drugs and oral drugs. The regional segmentation includes North America, Latin America, Europe, Asia Pacific and Middle East & Africa regions respectively.
Some Of The Growth Factors Of This Market:
- Fosfomycin is a broad-spectrum antibiotic that is used to treat bacterial infections of the urinary tract, lungs, and other parts of the body.
- Fosfomycin has been shown to be effective against many strains of bacteria including E.
- Fosfomycin is not absorbed from the gastrointestinal tract and must be given by injection or intravenously for systemic use in order to achieve therapeutic concentrations in the blood stream.
- The drug can also be given orally for local treatment of infections in the urinary tract or lungs.
- The drug has a low potential for development of resistance.
Industry Growth Insights published a new data on “Fosfomycin Market”. The research report is titled “Fosfomycin Market research by Types (Fosfomycin Calcium, Fosfomycin Sodium, Fosfomycin Trometamol), By Applications (Injection Drugs, Oral Drugs), By Players/Companies Northeast Pharm, Ercros, Shinpoong Pharm, Interquim, Manus Aktteva Biopharma LLP, Selectchemie, Hunan Huana Pharmaceuticals, Hubei Xunda Pharmaceutical Co.,Ltd., Guilin Hwasun, FarmaSino Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fosfomycin Market Research Report
By Type
Fosfomycin Calcium, Fosfomycin Sodium, Fosfomycin Trometamol
By Application
Injection Drugs, Oral Drugs
By Companies
Northeast Pharm, Ercros, Shinpoong Pharm, Interquim, Manus Aktteva Biopharma LLP, Selectchemie, Hunan Huana Pharmaceuticals, Hubei Xunda Pharmaceutical Co.,Ltd., Guilin Hwasun, FarmaSino Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Fosfomycin Market Report Segments:
The global Fosfomycin market is segmented on the basis of:
Types
Fosfomycin Calcium, Fosfomycin Sodium, Fosfomycin Trometamol
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Injection Drugs, Oral Drugs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Northeast Pharm
- Ercros
- Shinpoong Pharm
- Interquim
- Manus Aktteva Biopharma LLP
- Selectchemie
- Hunan Huana Pharmaceuticals
- Hubei Xunda Pharmaceutical Co.,Ltd.
- Guilin Hwasun
- FarmaSino Pharmaceutical
Highlights of The Fosfomycin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fosfomycin Calcium
- Fosfomycin Sodium
- Fosfomycin Trometamol
- By Application:
- Injection Drugs
- Oral Drugs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fosfomycin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fosfomycin is a type of antibiotic that is used to treat infections caused by bacteria. It works by killing the bacteria.
Some of the major companies in the fosfomycin market are Northeast Pharm, Ercros, Shinpoong Pharm, Interquim, Manus Aktteva Biopharma LLP, Selectchemie, Hunan Huana Pharmaceuticals, Hubei Xunda Pharmaceutical Co.,Ltd., Guilin Hwasun, FarmaSino Pharmaceutical.
The fosfomycin market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fosfomycin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fosfomycin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fosfomycin Market - Supply Chain
4.5. Global Fosfomycin Market Forecast
4.5.1. Fosfomycin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fosfomycin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fosfomycin Market Absolute $ Opportunity
5. Global Fosfomycin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fosfomycin Market Size and Volume Forecast by Type
5.3.1. Fosfomycin Calcium
5.3.2. Fosfomycin Sodium
5.3.3. Fosfomycin Trometamol
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fosfomycin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fosfomycin Market Size and Volume Forecast by Application
6.3.1. Injection Drugs
6.3.2. Oral Drugs
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fosfomycin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fosfomycin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fosfomycin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fosfomycin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fosfomycin Demand Share Forecast, 2019-2026
9. North America Fosfomycin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fosfomycin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fosfomycin Market Size and Volume Forecast by Application
9.4.1. Injection Drugs
9.4.2. Oral Drugs
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fosfomycin Market Size and Volume Forecast by Type
9.7.1. Fosfomycin Calcium
9.7.2. Fosfomycin Sodium
9.7.3. Fosfomycin Trometamol
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fosfomycin Demand Share Forecast, 2019-2026
10. Latin America Fosfomycin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fosfomycin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fosfomycin Market Size and Volume Forecast by Application
10.4.1. Injection Drugs
10.4.2. Oral Drugs
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fosfomycin Market Size and Volume Forecast by Type
10.7.1. Fosfomycin Calcium
10.7.2. Fosfomycin Sodium
10.7.3. Fosfomycin Trometamol
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fosfomycin Demand Share Forecast, 2019-2026
11. Europe Fosfomycin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fosfomycin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fosfomycin Market Size and Volume Forecast by Application
11.4.1. Injection Drugs
11.4.2. Oral Drugs
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fosfomycin Market Size and Volume Forecast by Type
11.7.1. Fosfomycin Calcium
11.7.2. Fosfomycin Sodium
11.7.3. Fosfomycin Trometamol
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Prduct Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fosfomycin Demand Share, 2019-2026
12. Asia Pacific Fosfomycin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fosfomycin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fosfomycin Market Size and Volume Forecast by Application
12.4.1. Injection Drugs
12.4.2. Oral Drugs
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fosfomycin Market Size and Volume Forecast by Type
12.7.1. Fosfomycin Calcium
12.7.2. Fosfomycin Sodium
12.7.3. Fosfomycin Trometamol
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fosfomycin Demand Share, 2019-2026
13. Middle East & Africa Fosfomycin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fosfomycin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fosfomycin Market Size and Volume Forecast by Application
13.4.1. Injection Drugs
13.4.2. Oral Drugs
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fosfomycin Market Size and Volume Forecast by Type
13.7.1. Fosfomycin Calcium
13.7.2. Fosfomycin Sodium
13.7.3. Fosfomycin Trometamol
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fosfomycin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fosfomycin Market: Market Share Analysis
14.2. Fosfomycin Distributors and Customers
14.3. Fosfomycin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Northeast Pharm
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ercros
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shinpoong Pharm
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Interquim
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Manus Aktteva Biopharma LLP
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Selectchemie
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hunan Huana Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hubei Xunda Pharmaceutical Co.,Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Guilin Hwasun
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. FarmaSino Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
